Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vered Schechner

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Trials|October 17, 2025
Examining tailoring as an implementation strategy for reducing healthcare-associated infections across European acute care hospitals (REVERSE): study protocol for a hybrid type 2 effectiveness-implementation trialBianca Albers, Laura Caci, Kathrin Blum, et al.
The Journal of Antimicrobial Chemotherapy|December 15, 2023
Use of Fourier-transform infrared spectroscopy for real-time outbreak investigation of OXA-48-producing Escherichia coliHadas Kon, Mor N Lurie-Weinberger, Carmela Lugassy, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamasesDror Marchaim, Tamar Gottesman, Orna Schwartz, et al.
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Diagnostic Microbiology and Infectious Disease|July 19, 2011
Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapyVered Schechner, Tamar Gottesman, Orna Schwartz, et al.
Infection Control and Hospital Epidemiology|April 6, 2018
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniaeOded Scheuerman, Vered Schechner, Yehuda Carmeli, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Trials|October 17, 2025
Examining tailoring as an implementation strategy for reducing healthcare-associated infections across European acute care hospitals (REVERSE): study protocol for a hybrid type 2 effectiveness-implementation trialBianca Albers, Laura Caci, Kathrin Blum, et al.
The Journal of Antimicrobial Chemotherapy|December 15, 2023
Use of Fourier-transform infrared spectroscopy for real-time outbreak investigation of OXA-48-producing Escherichia coliHadas Kon, Mor N Lurie-Weinberger, Carmela Lugassy, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2010
National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamasesDror Marchaim, Tamar Gottesman, Orna Schwartz, et al.
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Diagnostic Microbiology and Infectious Disease|July 19, 2011
Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapyVered Schechner, Tamar Gottesman, Orna Schwartz, et al.
Infection Control and Hospital Epidemiology|April 6, 2018
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniaeOded Scheuerman, Vered Schechner, Yehuda Carmeli, et al.
Pageof 5